Findings of a preliminary study published in The Lancet Respiratory Medicine suggest that a patient's own bone-marrow stromal (stem) cells could be used to treat multidrug-resistant (MDR) and extensively-drug (XDR) tuberculosis (TB). ...
Tags: bone-marrow stromal cells, multidrug-resistant tuberculosis
A patient's own bone marrow stem cells might someday be used to treat multidrug-resistant tuberculosis, a new study suggests. The phase 1 study to assess the safety of the treatment included 30 patients, aged 21 to 65, with ...